Brief: Wilex says secures financing commitment from main shareholder Dievini
Feb 6 (Reuters) - Wilex AG WL6G.DE :
* Secures financing commitment from its main shareholder
Dievini
* Detailed form of financing will be decided by management
and supervisory boards of Wilex AG as well as Dievini at a later
date
* Main shareholder Dievini Hopp Biotech Holding GmbH & Co.
Kg. Dievini will provide company up to 10 million euros ($10.75
million)
* With this additional commitment, company's cash reach is
secured until end of Q2 of 2018
Source text for Eikon: ID:nEQ3VN47m
Further company coverage: WL6G.DE
($1 = 0.9306 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Heidelberg Pharma AG
See all newsBrief: Heidelberg Pharma And Huadong Medicine Receive Nmpa Approval For Hdp-101 Trial In China
Germany's Heidelberg Pharma H1 sales revenue surges, driven by milestone payments
Brief: Heidelberg Pharma Says Co. And Healthcare Royalty Announce Amendment To Existing Royalty Agreement
Brief: Redhill Biopharma Secures Allowance Of Key Chinese Patent Application For Proprietary COVID-19 Treatment, RHB-107
Brief: Heidelberg Pharma Amends Royalty Financing With Healthcare Royalty